Results 151 to 160 of about 377,839 (219)

Measles, mumps, rubella (MMR) vaccine – a reply (2)

Ceylon Medical Journal, 2011
openaire   +3 more sources

Measles, mumps, rubella (MMR) vaccine – a reply (1)

Ceylon Medical Journal, 2011
openaire   +3 more sources

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial. [PDF]

Hum Vaccin Immunother
Habib MA, Hughes T, Huang LM, Deseda C, Zavadska D, Povey M, Raja R, Demoitié MA, Kondagunta VH, MMRVNS 20-001 study group.   +9 more
europepmc   +1 more source

Live viral measles-mumps-rubella revaccination and varicella vaccination in children and adolescents with juvenile idiopathic arthritis: a systematic review. [PDF]

Eur J Pediatr
Dipasquale RF, Sinopoli P, Mendicino A, Gallizzi R.   +3 more
europepmc   +1 more source

Mumps Vaccination Policies and Epidemiological Consequences: A Comparative Review of the United States and Japan. [PDF]

Epidemiologia (Basel)
Otani N, Ohmuraya M, Okuno T.
europepmc   +1 more source

Recurrent Mumps in a Fully Vaccinated Young Adult With a Prior Breakthrough Infection: A Case Report. [PDF]

Cureus
Ramadugu R, Pidikiti CV, Cordero Peña A, Almonte A, Garrido Flores I, Almonte A, Gonzalez JL, Kandi V.   +7 more
europepmc   +1 more source

Vitamin A and body weight status do not impact humoral immunity against measles, mumps or rubella in individuals 4 to 18 years old: a cross-sectional cohort study in India. [PDF]

Vaccine
Ratishvili T, Teodoro LI, Quach HQ, Ovsyannikova IG, Jones SP, Joseph I, Pillai MR, Poland GA, Jacob J, Kennedy RB.   +9 more
europepmc   +1 more source

Safe seroconversion after receiving measles, mumps, and rubella live vaccine during guselkumab treatment for psoriasis. [PDF]

JAAD Case Rep
Kim K, Kirshen C.
europepmc   +1 more source